This study identifies a putative mechanism for agonist-induced regulation of myosin phosphatase activity in human platelets via Rho-kinase mediated phosphorylation of the myosin-binding subunit.
Answers are grounded in this paper and cite their sources.
No clinical implications from this animal study; leaves open Rho-kinase modulation of platelet myosin phosphatase in humans.
Human platelets were found to contain myosin phosphatase consisting of a 38-kD catalytic subunit of protein phosphatase type 1delta, a 130-kD myosin-binding subunit (MBS) and a 20-kD subunit, all of which cross-reacted with antibodies against these subunits of smooth muscle myosin phosphatase. Anti-MBS antibody coimmunoprecipitated RhoA and Rho-kinase of human platelets. Platelets MBS is a substrate for Rho-kinase and phosphorylation of MBS decreases the activity of myosin phosphatase. Treatment of intact platelets with 9, 11-epithio-11,12-methano-thromboxane A2 led to a dramatic increase in phosphorylation of MBS and a significant decrease in the activity of myosin phosphatase. These findings suggest a putative mechanism for agonist-induced regulation of myosin phosphatase activity in platelets.
No takes yet. Share an insight, caveat, or question.
Nakai et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: